|
21. Manji HK, Chen G, Shimon H, Hsiao
JK, Potter WZ, Belmaker RH. Guanine nucleotide–binding proteins
in bipolar affective disorder. Effects of long–term lithium
treatment. Arch Gen Psychiatry 1995;52:135–44.
22. Mitchell PB, Manji HK, Chen G, Jolkovsky L, Smith–Jackson
E, Denicoff K and others. High levels of Gs alpha in platelets of
euthymic patients with bipolar affective disorder. Am J Psychiatry
1997;154:218–23.
23. Spleiss O, van Calker D, Scharer L, Adamovic K, Berger M, Gebicke–Haerter
PJ. Abnormal G protein alpha(s) – and alpha(i2)–subunit
mRNA expression in bipolar affective disorder. Mol Psychiatry 1998;3:512–20.
24. Young LT, Li PP, Kamble A, Siu KP, Warsh JJ. Mononuclear leukocyte
levels of G proteins in depressed patients with bipolar disorder
or major depressive disorder. Am J Psychiatry 1994;151:594–6.
25. Alda M, Keller D, Grof E, Turecki G, Cavazzoni P, Duffy A and
others. Is lithium response related to G(s)alpha levels in transformed
lymphoblasts from subjects with bipolar disorder? J Affect Disord
2001;65:117–22.
26. Gejman PV, Martinez M, Cao Q, Friedman E, Berrettini WH, Goldin
LR and others. Linkage analysis of fifty–seven microsatellite
loci to bipolar disorder. Neuropsychopharmacology 1993;9:31–40.
27. Le F, Mitchell P, Vivero C, Waters B, Donald J, Selbie LA and
others. Exclusion of close linkage of bipolar disorder to the Gs–alpha
subunit gene in nine Australian pedigrees. J Affect Disord 1994;32:187–95.
28. Ram A, Guedj F, Cravchik A, Weinstein L, Cao Q, Badner JA and
others. No abnormality in the gene for the G protein stimulatory
alpha subunit in patients with bipolar disorder. Arch Gen Psychiatry
1997;54:44–8.
29. Young LT, Asghari V, Li PP, Kish SJ, Fahnestock M, Warsh JJ.
Stimulatory G–protein alpha–subunit mRNA levels are not
increased in autopsied cerebral cortex from patients with bipolar
disorder. Brain Res Mol Brain Res 1996;42:45–50.
30. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications
of multiple isoforms. Physiol Rev 1995;75:725–48.
31. Beavo JA, Bechtel PJ, Krebs EG. Activation of protein kinase
by physiological concentrations of cyclic AMP. Proc Natl Acad Sci
U S A 1974;71:3580–3.
32. Scott JD. Cyclic nucleotide–dependent protein kinases.
Pharmacol Ther 1991;50:123–45.
33. Avissar S, Barki–Harrington L, Nechamkin Y, Roitman G,
Schreiber G. Reduced beta–adrenergic receptor–coupled
Gs protein function and Gs alpha immunoreactivity in mononuclear
leukocytes of patients with depression. Biol Psychiatry 1996;39:755–60.
34. Ebstein RP, Lerer B, Bennett ER, Shapira B, Kindler S, Shemesh
Z and others. Lithium modulation of second messenger signal amplification
in man: inhibition of phosphatidylinositol–specific phospholipase
C and adenylate cyclase activity. Psychiatry Res 1988;24:45–52.
35. Rahman S, Li PP, Young LT, Kofman O, Kish SJ, Warsh JJ. Reduced
[3H]cyclic AMP binding in postmortem brain from subjects with bipolar
affective disorder. J Neurochem 1997;68:297–304.
36. Zanardi R, Racagni G, Smeraldi E, Perez J. Differential effects
of lithium on platelet protein phosphorylation in bipolar patients
and healthy subjects. Psychopharmacology (Berl) 1997;129:44–7.
37. Spaulding SW. The ways in which hormones change cyclic adenosine
3’,5’–monophosphate–dependent protein kinase
subunits, and how such changes affect cell behavior. Endocr Rev
1993;14:632–50.
38. Fields A, Li PP, Kish SJ, Warsh JJ. Increased cyclic AMP–dependent
protein kinase activity in postmortem brain from patients with bipolar
affective disorder. J Neurochem 1999;73:1704–10.
39. Perez J, Tardito D, Mori S, Racagni G, Smeraldi E, Zanardi R.
Abnormalities of cyclic adenosine monophosphate signaling in platelets
from untreated patients with bipolar disorder. Arch Gen Psychiatry
1999;56:248–53.
40. Perez J, Zanardi R, Mori S, Gasperini M, Smeraldi E, Racagni
G. Abnormalities of cAMP–dependent endogenous phosphorylation
in platelets from patients with bipolar disorder. Am J Psychiatry
1995;152:1204–6.
41. Siever LJ, Kafka MS, Targum S, Lake CR. Platelet alpha–adrenergic
binding and biochemical responsiveness in depressed patients and
controls. Psychiatry Res 1984;11:287–302.
42. Perez J, Tardito D, Mori S, Racagni G, Smeraldi E, Zanardi R.
Altered Rap1 endogenous phosphorylation and levels in platelets
from patients with bipolar disorder. J Psychiatr Res 2000;34:99–104.
43. Smrcka AV, Hepler JR, Brown KO, Sternweis PC. Regulation of
polyphosphoinositide–specific phospholipase C activity by purified
Gq. Science 1991;251:804–7.
44. Berridge MJ. 5–Hydroxytryptamine stimulation of phosphatidylinositol
hydrolysis and calcium signalling in the blowfly salivary gland.
Cell Calcium 1982;3:385–97.
45. Snyder SH, Supattapone S. Isolation and functional characterization
of an inositol trisphosphate receptor from brain. Cell Calcium 1989;10:337–42.
46. Atack JR, Broughton HB, Pollack SJ. Structure and mechanism
of inositol monophosphatase. FEBS Lett 1995;361:1–7.
47. Banks RE, Aiton JF, Cramb G, Naylor GJ. Incorporation of inositol
into the phosphoinositides of lymphoblastoid cell lines established
from bipolar manic–depressive patients. J Affect Disord 1990;19:1–8.48.
Mori H, Koyama T, Yamashita I. Platelet alpha–2 adrenergic
receptor–mediated phosphoinositide responses in endogenous
depression. Life Sci 1991;48:741–8.
49. Shimon H, Agam G, Belmaker RH, Hyde TM, Kleinman JE. Reduced
frontal cortex inositol levels in postmortem brain of suicide victims
and patients with bipolar disorder. Am J Psychiatry 1997;154:1148–50.
50. Moscovich DG, Belmaker RH, Agam G, Livne A. Inositol–1–phosphatase
in red blood cells of manic–depressive patients before and
during treatment with lithium. Biol Psychiatry 1990;27:552–5.
51. Moore GJ, Bebchuk JM, Parrish JK, Faulk MW, Arfken CL, Strahl–Bevacqua
J and others. Temporal dissociation between lithium–induced
changes in frontal lobe myo–inositol and clinical response
in manic–depressive illness. Am J Psychiatry 1999;156:1902–8.
52. Brown AS, Mallinger AG, Renbaum LC. Elevated platelet membrane
phosphatidylinositol–4,5–bisphosphate in bipolar mania.
Am J Psychiatry 1993;150:1252–4.
53. Soares JC, Dippold CS, Wells KF, Frank E, Kupfer DJ, Mallinger
AG. Increased platelet membrane phosphatidylinositol–4,5–bisphosphate
in drug–free depressed bipolar patients. Neurosci Lett 2001;299:150–2.
54. Soares JC, Dippold CS, Mallinger AG. Platelet membrane phosphatidylinositol–4,5–bisphosphate
alterations in bipolar disorder––evidence from a single
case study. Psychiatry Res 1997;69:197–202.
55. Soares JC, Mallinger AG, Dippold CS, Frank E, Kupfer DJ. Platelet
membrane phospholipids in euthymic bipolar disorder patients: are
they affected by lithium treatment? Biol Psychiatry 1999;45:453–7.
56. Soares JC, Chen G, Dippold CS, Wells KF, Frank E, Kupfer DJ
and others. Concurrent measures of protein kinase C and phosphoinositides
in lithium–treated bipolar patients and healthy individuals:
a preliminary study. Psychiatry Res 2000;95:109–18.
57. Soares JC, Mallinger AG, Dippold CS, Forster WK, Frank E, Kupfer
DJ. Effects of lithium on platelet membrane phosphoinositides in
bipolar disorder patients: a pilot study. Psychopharmacology (Berl)
2000;149:12–6.
58. Strathmann M, Simon MI. G protein diversity: a distinct class
of alpha subunits is present in vertebrates and invertebrates. Proc
Natl Acad Sci U S A 1990;87:9113–7.
59. Taylor SJ, Exton JH. Two alpha subunits of the Gq class of G
proteins stimulate phosphoinositide phospholipase C–beta 1
activity. FEBS Lett 1991;286:214–6.
60. Mathews R, Li PP, Young LT, Kish SJ, Warsh JJ. Increased G alpha
q/11 immunoreactivity in postmortem occipital cortex from patients
with bipolar affective disorder. Biol Psychiatry 1997;41:649–56.
61. Jope RS, Song L, Li PP, Young LT, Kish SJ, Pacheco MA and others.
The phosphoinositide signal transduction system is impaired in bipolar
affective disorder brain. J Neurochem 1996;66:2402–9.
62. Turecki G, Grof P, Cavazzoni P, Duffy A, Grof E, Ahrens B and
others. Evidence for a role of phospholipase C–gamma1 in the
pathogenesis of bipolar disorder. Mol Psychiatry 1998;3:534–8.
63. Lovlie R, Berle JO, Stordal E, Steen VM. The phospholipase C–gamma1
gene (PLCG1) and lithium–responsive bipolar disorder: re–examination
of an intronic dinucleotide repeat polymorphism. Psychiatr Genet
2001;11:41–3.
64. Friedman E, Hoau YW, Levinson D, Connell TA, Singh H. Altered
platelet protein kinase C activity in bipolar affective disorder,
manic episode. Biol Psychiatry 1993;33:520–5.
65. Wang HY, Markowitz P, Levinson D, Undie AS, Friedman E. Increased
membrane–associated protein kinase C activity and translocation
in blood platelets from bipolar affective disorder patients. J Psychiatr
Res 1999;33:171–9.
66. Wang HY, Friedman E. Lithium inhibition of protein kinase C
activation–induced serotonin release. Psychopharmacology (Berl)
1989;99:213–8.
67. Weiss S, Ellis J, Hendley DD, Lenox RH. Translocation and activation
of protein kinase C in striatal neurons in primary culture: relationship
to phorbol dibutyrate actions on the inositol phosphate generating
system and neurotransmitter release. J Neurochem 1989;52:530–6.
68. Wang HY, Friedman E. Protein kinase C translocation in human
blood platelets. Life Sci 1990;47:1419–25.
69. Wang HY, Friedman E. Enhanced protein kinase C activity and
translocation in bipolar affective disorder brains. Biol Psychiatry
1996;40:568–75.
70. Pandey GN, Dwivedi Y, Kumari R, Janicak PG. Protein kinase C
in platelets of depressed patients. Biol Psychiatry 1998;44:909–11.
71. Pandey GN, Dwivedi Y, Pandey SC, Conley RR, Roberts RC, Tamminga
CA. Protein kinase C in the postmortem brain of teenage suicide
victims. Neurosci Lett 1997;228:111–4.
72. Bebchuk JM, Arfken CL, Dolan–Manji S, Murphy J, Hasanat
K, Manji HK. A preliminary investigation of a protein kinase C inhibitor
in the treatment of acute mania. Arch Gen Psychiatry 2000;57:95–7.
73. Lapetina EG, Watson SP, Cuatrecasas P. myo–Inositol 1,4,5–trisphosphate
stimulates protein phosphorylation in saponin–permeabilized
human platelets. Proc Natl Acad Sci U S A 1984;81:7431–5.
74. Matthews EK. Calcium and membrane permeability. Br Med Bull
1986;42:391–7.
75. Rasmussen H. The calcium messenger system (1). N Engl J Med
1986;314:1094–101.
76. Alkon DL, Kubota M, Neary JT, Naito S, Coulter D, Rasmussen
H. C–kinase activation prolongs Ca2+–dependent inactivation
of K+ currents. Biochem Biophys Res Commun 1986;134:1245–53.
77. Tsien RW, Lipscombe D, Madison DV, Bley KR, Fox AP. Multiple
types of neuronal calcium channels and their selective modulation.
Trends Neurosci 1988;11:431–8.
78. Clapham DE. Intracellular calcium. Replenishing the stores.
Nature 1995;375:634–5.
79. Eberhard M, Erne P. Regulation of inositol 1,4,5–trisphosphate–induced
calcium release by inositol 1,4,5–trisphosphate and calcium
in human platelets. J Recept Signal Transduct Res 1995;15:297–309.
80. Carafoli E. Intracellular calcium homeostasis. Annu Rev Biochem
1987;56:395–433.
81. Blaustein MP. Sodium/calcium exchange and the control of contractility
in cardiac muscle and vascular smooth muscle. J Cardiovasc Pharmacol
1988;12 Suppl 5:S56–S68.
82. Schulman H. The multifunctional Ca2+/calmodulin–dependent
protein kinases. Curr Opin Cell Biol 1993;5:247–53.
83. Ghosh A, Greenberg ME. Calcium signaling in neurons: molecular
mechanisms and cellular consequences. Science 1995;268:239–47.
84. Matthews RP, Guthrie CR, Wailes LM, Zhao X, Means AR, McKnight
GS. Calcium/calmodulin–dependent protein kinase types II and
IV differentially regulate CREB–dependent gene expression.
Mol Cell Biol 1994;14:6107–16.
85. Carman JS, Post RM, Runkle DC, Bunney WE, Jr., Wyatt RJ. Increased
serum calcium and phosphorus with the ‘switch’ into manic
or excited psychotic state. Br J Psychiatry 1979;135:55–61.
86. Dubovsky SL, Murphy J, Thomas M, Rademacher J. Abnormal intracellular
calcium ion concentration in platelets and lymphocytes of bipolar
patients. Am J Psychiatry 1992;149:118–20.
87. Dubovsky SL, Christiano J, Daniell LC, Franks RD, Murphy J,
Adler L and others. Increased platelet intracellular calcium concentration
in patients with bipolar affective disorders. Arch Gen Psychiatry
1989;46:632–8.
88. Dubovsky SL, Lee C, Christiano J, Murphy J. Elevated platelet
intracellular calcium concentration in bipolar depression. Biol
Psychiatry 1991;29:441–50.
89. Dubovsky SL, Thomas M, Hijazi A, Murphy J. Intracellular calcium
signalling in peripheral cells of patients with bipolar affective
disorder. Eur Arch Psychiatry Clin Neurosci 1994;243:229–34.
90. Dubovsky SL, Murphy J, Christiano J, Lee C. The calcium second
messenger system in bipolar disorders: data supporting new research
directions. J Neuropsychiatry Clin Neurosci 1992;4:3–14.
91. Hough C, Lu SJ, Davis CL, Chuang DM, Post RM. Elevated basal
and thapsigargin–stimulated intracellular calcium of platelets
and lymphocytes from bipolar affective disorder patients measured
by a fluorometric microassay. Biol Psychiatry 1999;46:247–55.
92. Yamawaki S, Kagaya A, Okamoto Y, Shimizu M, Nishida A, Uchitomi
Y. Enhanced calcium response to serotonin in platelets from patients
with affective disorders. J Psychiatry Neurosci 1996;21:321–4.
93. Kusumi I, Koyama T, Yamashita I. Effect of mood stabilizing
agents on agonist–induced calcium mobilization in human platelets.
J Psychiatry Neurosci 1994;19:222–5.
94. Berk M, Kirchmann NH, Butkow N. Lithium blocks 45Ca2+ uptake
into platelets in bipolar affective disorder and controls. Clin
Neuropharmacol 1996;19:48–51.
95. Bothwell RA, Eccleston D, Marshall E. Platelet intracellular
calcium in patients with recurrent affective disorders. Psychopharmacology
(Berl) 1994;114:375–81.
96. Berk M, Bodemer W, van Oudenhove T, Butkow N. Dopamine increases
platelet intracellular calcium in bipolar affective disorder and
controls. Int Clin Psychopharmacol 1994;9:291–3.
97. Suzuki K, Kusumi I, Sasaki Y, Koyama T. Serotonin–induced
platelet intracellular calcium mobilization in various psychiatric
disorders: is it specific to bipolar disorder? J Affect Disord 2001;64:291–6.
98. Kusumi I, Koyama T, Yamashita I. Serotonin–stimulated Ca2+
response is increased in the blood platelets of depressed patients.
Biol Psychiatry 1991;30:310–2.
99. Yatani A, Imoto Y, Codina J, Hamilton SL, Brown AM, Birnbaumer
L. The stimulatory G protein of adenylyl cyclase, Gs, also stimulates
dihydropyridine–sensitive Ca2+ channels. Evidence for direct
regulation independent of phosphorylation by cAMP–dependent
protein kinase or stimulation by a dihydropyridine agonist. J Biol
Chem 1988;263:9887–95.
100. Yatani A, Codina J, Imoto Y, Reeves JP, Birnbaumer L, Brown
AM. A G protein directly regulates mammalian cardiac calcium channels.
Science 1987;238:1288–92.
101. Emamghoreishi M, Li PP, Schlichter L, Parikh SV, Cooke R, Warsh
JJ. Associated disturbances in calcium homeostasis and G protein–mediated
cAMP signaling in bipolar I disorder. Biol Psychiatry 2000;48:665–73.
102. Kusumi I, Koyama T, Yamashita I. Thrombin–induced platelet
calcium mobilization is enhanced in bipolar disorders. Biol Psychiatry
1992;32:731–4.
103. Kusumi I, Suzuki K, Sasaki Y, Kameda K, Koyama T. Treatment
response in depressed patients with enhanced Ca mobilization stimulated
by serotonin. Neuropsychopharmacology 2000;23:690–6.
104. Eckert A, Gann H, Riemann D, Aldenhoff J, Muller WE. Elevated
intracellular calcium levels after 5–HT2 receptor stimulation
in platelets of depressed patients. Biol Psychiatry 1993;34:565–8.
105. Eckert A, Gann H, Riemann D, Aldenhoff J, Muller WE. Platelet
and lymphocyte free intracellular calcium in affective disorders.
Eur Arch Psychiatry Clin Neurosci 1994;243:235–9.
106. Kusumi I, Koyama T, Yamashita I. Serotonin–induced platelet
intracellular calcium mobilization in depressed patients. Psychopharmacology
(Berl) 1994;113:322–7.
107. Okamoto Y, Kagaya A, Shinno H, Motohashi N, Yamawaki S. Serotonin–induced
platelet calcium mobilization is enhanced in mania. Life Sci 1995;56:327–32.
108. Tan CH, Javors MA, Seleshi E, Lowrimore PA, Bowden CL. Effects
of lithium on platelet ionic intracellular calcium concentration
in patients with bipolar (manic–depressive) disorder and healthy
controls. Life Sci 1990;46:1175–80.
109. Emamghoreishi M, Schlichter L, Li PP, Parikh S, Sen J, Kamble
A and others. High intracellular calcium concentrations in transformed
lymphoblasts from subjects with bipolar I disorder. Am J Psychiatry
1997;154:976–82.
110. Stewart RJ, Chen B, Dowlatshahi D, MacQueen GM, Young LT. Abnormalities
in the cAMP signaling pathway in post–mortem brain tissue from
the Stanley Neuropathology Consortium. Brain Res Bull 2001;55:625–9.
111. Linnoila M, MacDonald E, Reinila M, Leroy A, Rubinow DR, Goodwin
FK. RBC membrane adenosine triphosphatase activities in patients
with major affective disorders. Arch Gen Psychiatry 1983;40:1021–6.
112. Bowden CL, Huang LG, Javors MA, Johnson JM, Seleshi E, McIntyre
K and others. Calcium function in affective disorders and healthy
controls. Biol Psychiatry 1988;23:367–76.
113. Meltzer HL, Kassir S, Goodnick PJ, Fieve RR, Chrisomalis L,
Feliciano M and others. Calmodulin–activated calcium ATPase
in bipolar illness. Neuropsychobiology 1988;20:169–73.
114. Hokin–Neaverson M, Spiegel DA, Lewis WC. Deficiency of
erythrocyte sodium pump activity in bipolar manic–depressive
psychosis. Life Sci 1974;15:1739–48.
115. Johnston BB, Naylor GJ, Dick EG, Hopwood SE, Dick DA. Prediction
of clinical course of bipolar manic depressive illness treated with
lithium. Psychol Med 1980;10:329–34.
116. Naylor GJ. Reversal of vanadate–induced inhibition of
Na–K ATPase. A possible explanation of the therapeutic effect
of carbamazepine in affective illness. J Affect Disord 1985;8:91–3.
117. Cherry L, Swann AC. Cation transport mediated by Na+,K(+)–adenosine
triphosphatase in lymphoblastoma cells from patients with bipolar
I disorder, their relatives, and unrelated control subjects. Psychiatry
Res 1994;53:111–8.
118. Sheng M, Greenberg ME. The regulation and function of c–fos
and other immediate early genes in the nervous system. Neuron 1990;4:477–85.
119. Meyer TE, Habener JF. Cyclic adenosine 3’,5’–monophosphate
response element binding protein (CREB) and related transcription–activating
deoxyribonucleic acid–binding proteins. Endocr Rev 1993;14:269–90.
120. Shaywitz AJ, Greenberg ME. CREB: a stimulus–induced transcription
factor activated by a diverse array of extracellular signals. Annu
Rev Biochem 1999;68:821–61.
121. Montminy MR, Sevarino KA, Wagner JA, Mandel G, Goodman RH.
Identification of a cyclic–AMP–responsive element within
the rat somatostatin gene. Proc Natl Acad Sci U S A 1986;83:6682–6.
122. Nibuya M, Nestler EJ, Duman RS. Chronic antidepressant administration
increases the expression of cAMP response element binding protein
(CREB) in rat hippocampus. J Neurosci 1996;16:2365–72.
123. Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased temporal
cortex CREB concentrations and antidepressant treatment in major
depression. Lancet 1998;352:1754–5.
124. Ozaki N, Chuang DM. Lithium increases transcription factor
binding to AP–1 and cyclic AMP–responsive element in cultured
neurons and rat brain. J Neurochem 1997;69:2336–44.
125. Chen G, Yuan PX, Jiang YM, Huang LD, Manji HK. Valproate robustly
enhances AP–1 mediated gene expression. Brain Res Mol Brain
Res 1999;64:52–8.
126. Wang JF, Asghari V, Rockel C, Young LT. Cyclic AMP responsive
element binding protein phosphorylation and DNA binding is decreased
by chronic lithium but not valproate treatment of SH–SY5Y neuroblastoma
cells. Neuroscience 1999;91:771–6.
127. Shaw M, Cohen P, Alessi DR. The activation of protein kinase
B by H2O2 or heat shock is mediated by phosphoinositide 3–kinase
and not by mitogen–activated protein kinase–activated
protein kinase–2. Biochem J 1998;336 ( Pt 1):241–6.
128. Papkoff J, Aikawa M. WNT–1 and HGF regulate GSK3 beta
activity and beta–catenin signaling in mammary epithelial cells.
Biochem Biophys Res Commun 1998;247:851–8.
129. Pelech SL, Charest DL. MAP kinase–dependent pathways in
cell cycle control. Prog Cell Cycle Res 1995;1:33–52.
130. Singh TJ, Grundke–Iqbal I, Iqbal K. Differential phosphorylation
of human tau isoforms containing three repeats by several protein
kinases. Arch Biochem Biophys 1996;328:43–50.
131. Guan RJ, Khatra BS, Cohlberg JA. Phosphorylation of bovine
neurofilament proteins by protein kinase FA (glycogen synthase kinase
3). J Biol Chem 1991;266:8262–7.
132. Yang SD. Identification of the ATP.Mg–dependent protein
phosphatase activator (FA) as a myelin basic protein kinase in the
brain. J Biol Chem 1986;261:11786–91.
133. Taniuchi M, Johnson EM, Jr., Roach PJ, Lawrence JC, Jr. Phosphorylation
of nerve growth factor receptor proteins in sympathetic neurons
and PC12 cells. In vitro phosphorylation by the cAMP–independent
protein kinase FA/GSK–3. J Biol Chem 1986;261:13342–9.
134. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase
kinase 3beta in cellular signaling. Prog Neurobiol 2001;65:391–426.
135. Chen G, Huang LD, Jiang YM, Manji HK. The mood–stabilizing
agent valproate inhibits the activity of glycogen synthase kinase–3.
J Neurochem 1999;72:1327–30.
136. Grimes CA, Jope RS. CREB DNA binding activity is inhibited
by glycogen synthase kinase–3 beta and facilitated by lithium.
J Neurochem 2001;78:1219–32.
137. Klein PS, Melton DA. A molecular mechanism for the effect of
lithium on development. Proc Natl Acad Sci U S A 1996;93:8455–9.
138. King TD, Bijur GN, Jope RS. Caspase–3 activation induced
by inhibition of mitochondrial complex I is facilitated by glycogen
synthase kinase–3beta and attenuated by lithium. Brain Res
2001;919:106–14.
139. Bhat RV, Shanley J, Correll MP, Fieles WE, Keith RA, Scott
CW and others. Regulation and localization of tyrosine216 phosphorylation
of glycogen synthase kinase–3beta in cellular and animal models
of neuronal degeneration. Proc Natl Acad Sci U S A 2000;97:11074–9.
140. Bijur GN, De Sarno P, Jope RS. Glycogen synthase kinase–3beta
facilitates staurospo. J Biol Chem 2000;275:7583–90.
141. Lesort M, Greendorfer A, Stockmeier C, Johnson GV, Jope RS.
Glycogen synthase kinase–3beta, beta–catenin, and tau
in postmortem bipolar brain. J Neural Transm 1999;106:1217–22.
142. Kozlovsky N, Belmaker RH, Agam G. Low GSK–3beta immunoreactivity
in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry
2000;157:831–3.
143. Bezchlibnyk YB, Wang JF, MacQueen G, Young LT. Gene expression
differences in bipolar disorder revealed by cDNA array analysis
of postmortem frontal cortex. J Neurochem 2001;79:826–34.
144. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH and others.
The mood–stabilizing agents lithium and valproate robustly
increase the levels of the neuroprotective protein bcl–2 in
the CNS. J Neurochem 1999;72:879–82.
145. Wang JF, Young LT. Differential display PCR reveals increased
expression of 2’,3’–cyclic nucleotide 3’–phosphodiesterase
by lithium. FEBS Lett 1996;386:225–9.
146. Wang JF, Chen B, Young LT. Identification of a novel lithium
regulated gene in rat brain. Brain Res Mol Brain Res 1999;70:66–73.
147. Wang JF, Bown CD, Chen B, Young LT. Identification of mood
stabilizer–regulated genes by differential–display PCR.
Int J Neuropsychopharmacol 2001;4:65–74.
148. Duman RS, Malberg J, Nakagawa S, D’Sa C. Neuronal plasticity
and survival in mood disorders. Biol Psychiatry 2000;48:732–9.
149. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular
theory of depression. Arch Gen Psychiatry 1997;54:597–606.
150. Post RM, Weiss SR. Sensitization, kindling, and anticonvulsants
in mania. J Clin Psychiatry 1989;50 Suppl:23–30.
151. Post RM. Transduction of psychosocial stress into the neurobiology
of recurrent affective disorder. Am J Psychiatry 1992;149:999–1010.
152. Post RM, Weiss SR. A speculative model of affective illness
cyclicity based on patterns of drug tolerance observed in amygdala–kindled
seizures. Mol Neurobiol 1996;13:33–60.
153. Karege F, Golaz J, Schwald M, Malafosse A. Lithium and haloperidol
treatments differently affect the mononuclear leukocyte Galphas
protein levels in bipolar affective disorder. Neuropsychobiology
1999;39:181–6.
154. Reiach JS, Li PP, Warsh JJ, Kish SJ, Young LT. Reduced adenylyl
cyclase immunolabeling and activity in postmortem temporal cortex
of depressed suicide victims. J Affect Disord 1999;56:141–51.
155. Young LT, Wang JF, Woods CM, Robb JC. Platelet protein kinase
C alpha levels in drug–free and lithium–treated subjects
with bipolar disorder. Neuropsychobiology 1999;40:63–6.
156. Naylor GJ, Smith AH, Dick EG, Dick DA, McHarg AM, Chambers
CA. Erythrocyte membrane cation carrier in manic–depressive
psychosis. Psychol Med 1980;10:521–5.
157. van Calker D, Forstner U, Bohus M, Gebicke–Harter P, Hecht
H, Wark HJ and others. Increased sensitivity to agonist stimulation
of the Ca2+ response in neutrophils of manic–depressive patients:
effect of lithium therapy. Neuropsychobiology 1993;27:180–3.
158. Forstner U, Bohus M, Gebicke–Harter PJ, Baumer B, Berger
M, van Calker D. Decreased agonist–stimulated Ca2+ response
in neutrophils from patients under chronic lithium therapy. Eur
Arch Psychiatry Clin Neurosci 1994;243:240–3.
--------------------------------------------------------------------------------
Manuscript received and accepted February 2002.
1PhD Candidate, Department of Psychiatry
and Behavioural Neurosciences, McMaster University, Hamilton, Ontario.
2Professor and Vice Chair of Research, Department
of Psychiatry and Behavioural Neurosciences, McMaster University,
Hamilton, Ontario.
Address for correspondence: Dr LT Young, McMaster University,
Department of Psychiatry and Behavioural Neurosciences, HSC–4N77A,
1200 Main St West, Hamilton, ON L8N 3Z5
e-mail: youngt@mcmaster.ca
|
